Lawrence K C Camarda

Università degli studi di Palermo, Palermo, Sicily, Italy

Are you Lawrence K C Camarda?

Claim your profile

Publications (7)20.89 Total impact

  • R Camarda · C Camarda · S Grimaldi · L K C Camarda · R Monastero · M Gangitano ·
    [Show abstract] [Hide abstract]
    ABSTRACT: We studied the time-course of a levodopa oral bolus effects on the kinematics of patients affected by a mild akinetic-rigid form of idiopathic Parkinson's disease (PD). Eleven PD patients were evaluated: a) in OFF-state, that is before their first medication or after its withdrawal, b) in ON-state, that is at 1/2, 1, 2, 3, 4, 5, 6, 24, 30 and 48 hours after the administration of 250 mg of levodopa plus 25mg of carbidopa. The main kinematics (i. e.movement time, peak of velocity, peak of acceleration and peak of deceleration) of pointing movements to six target-stimuli placed on the horizontal plane of a table were recorded. Clinical conditions were assessed according to the Motor Examination section of the Unified Parkinson's Disease Rating Scale. The levopoda bolus had stable clinical effects only within the first six hours from its administration. The decline of the clinical response was marked by the changes of peak acceleration whereas other kinematics (i. e. movement time and the peak of velocity) changed also in the late observations (24, 30 and 48 hours after drug intake). The dissociation between the persistent improvement on movement time on peak velocity and the rapid deterioration of levodopa effects on early kinematics (i. e. peak acceleration) could be accounted for by a progressive decline in movement programming.
    Journal of Neurology 10/2005; 252(9):1074-81. DOI:10.1007/s00415-005-0818-8 · 3.38 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: We investigated the prevalence of cognitive impairment in patients with Behçet's disease (BD) without overt neurological involvement. The influence of disease duration, disease activity, prednisone dosage, and anxiety and depression levels was evaluated. Twenty-six consecutive BD outpatients and 26 healthy controls matched for age, education and sex completed a comprehensive neuropsychological battery including tests of memory, visuospatial and constructional abilities, language, attention and psychomotor speed, non-verbal reasoning and executive functioning. The Hamilton scales for anxiety and depression were administered. Disease activity was assessed using the Behçet's Disease Current Activity Form (BDCAF). Compared to controls, BD patients were significantly impaired on tasks evaluating long-term verbal and non-verbal memory, and visuospatial skills. In addition, BD patients were significantly more anxious and depressed than controls. Cognitive impairment was evident in 46.1% of BD patients compared with none of control subjects (p<0.0001), with memory representing the cognitive domain most affected. Both high disease activity (OR 1.3, 95% CI 1.0-1.5, p<0.04) and high prednisone dosage (OR 1.3, 95% CI 1.0-1.7, p<0.03) were independently associated with cognitive impairment in BD after adjustment for demographic variables. Cognitive impairment, involving mainly memory functions, occurs frequently in BD patients. It may occur independently of clinically overt neurological involvement, and is more common in patients with an active disease and in those receiving prednisone.
    Journal of the Neurological Sciences 06/2004; 220(1-2):99-104. DOI:10.1016/j.jns.2004.02.021 · 2.47 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: A great amount of evidence suggests that neuroinflammation may be a major pathogenetic mechanism in the pathophysiology of sporadic Alzheimer's Disease (sAD). Recently, polymorphisms in the endothelial nitric oxide synthase (NOS3) gene have been associated to late onset Alzheimer's Disease in a British population. However, other groups failed to replicate this finding in Asiatic and Caucasian populations. We conducted a case-control study including a clinically well-defined group of 149 sAD patients and 149 age and sex matched controls to test the association between NOS3 Glu298Asp polymorphism and sAD in an ethnically homogenous Italian population. All subjects were genotyped at NOS3 and apolipoprotein E. No significant difference was found in either allele or genotype frequencies between cases and controls, even after stratification for Apolipoprotein E4 carrier status. The NOS3 Glu298Asp polymorphism does not appear to influence the risk of developing sAD in an Italian population.
    Neuroscience Letters 06/2003; 341(3):229-32. DOI:10.1016/S0304-3940(03)00210-6 · 2.03 Impact Factor
  • R Monastero · M Mannino · G Lopez · C Camarda · C Cannizzaro · L K C Camarda · F Ciccia · G Triolo · R Camarda ·
    [Show abstract] [Hide abstract]
    ABSTRACT: The aims of the present study were to evaluate the prevalence of headache and the frequency of different headache syndromes in patients with Behçet's Disease (BD) without neurological involvement and to investigate the relationship with other clinical, and behavioural variables. Twenty-seven BD patients and 27 control subjects underwent a validated semistructured questionnaire based on the International Headache Society criteria. Levels of anxiety and depression, disease activity, and current medication were collected. Headache occurred in 88.9% of BD patients. There was no difference in the prevalence of the different headache syndromes between BD patients and controls. Only migraine without aura (MwA) was significantly more frequent in BD patients than controls (44.4% vs. 11.1%, respectively, P= 0.013). No relationship was found between MwA and clinical, and behavioural variables. Among headache syndromes, MwA showed the highest frequency in BD. A vascular or neuronal subclinical dysfunction could justify this association. A careful interview for migraine might be included in the diagnostic work-up of BD.
    Cephalalgia 04/2003; 23(2):105-8. DOI:10.1046/j.1468-2982.2003.t01-1-00476.x · 4.89 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Epidemiological and pathogenetic evidences suggest a strong association between vascular risk factors and sporadic Alzheimer's disease (sAD). In agreement with the vascular hypothesis of AD, the role of various candidate genes for atherosclerosis has been investigated, leading to conflicting results. In order to clarify the significance of angiotensin-converting enzyme (ACE) gene insertion (I)/deletion (D) polymorphism in a group of patients with sAD, we conducted a case-control study including 149 cases and 149 age and sex matched controls. All subjects were genotyped for ACE and Apolipoprotein E (APOE). There were no significant differences in ACE genotype or allele frequencies between cases and controls, even after stratification for APOE4 carrier status. Our data suggest that the ACE I/D polymorphism is not associated to genetic susceptibility in sAD patients.
    Neuroscience Letters 01/2003; 335(2):147-9. DOI:10.1016/S0304-3940(02)01182-5 · 2.03 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Longitudinal studies of juvenile migraine are very few. We investigated the prevalence and evolution over 5 years of migraine without aura (MWOA) and migraineous disorder (MD) in an adolescent population. Sixty-four subjects (34 girls and 30 boys, mean age 17.3+/-1.1 years) out of 80 selected in our 1989 epidemiological survey were included in the study. The diagnostic criteria of the International Headache Society were used in both studies. Thirty-two of 64 subjects (50%) had MWAO, 18 (28.1%) had MD, and 14 (21.9%) had headache not classifiable (HnC). Our results show that MWOA persisted in 56.2%, converted to MD or HnC in 9.4% and 3.1% of cases, respectively, changed to episodic tension-type headache (ETTH) in 12.5%, and remitted in 18.8%. MD persisted in 11.1%, converted to MWOA or HnC in 27.8% and 5.5% of cases, respectively, changed to ETTH in 11.1%, and remitted in 44.5%. HnC persisted in 14.3%, converted to MD or MWOA in 21.4% and 14.3% of cases, respectively, changed to ETTH in 14.3%, and remitted in 35.7%. Our data indicate that juvenile-onset MWOA and MD may change in character over time, generally with a favorable prognosis.
    Headache The Journal of Head and Face Pain 11/2002; 42(10):1000-5. DOI:10.1046/j.1526-4610.2002.02229.x · 2.71 Impact Factor
  • Roberto Monastero · Carmela Pipia · Lawrence K.C. Camarda · Rosolino Camarda ·

    Journal of Neurology 03/2001; 248(2):141-2. DOI:10.1007/s004150170250 · 3.38 Impact Factor